Category: News

It was an honor to host Mr. Salvatore Parano, the Trade Commissioner, and Mr. Augusto Palmieri, the First Secretary Counsel of the Embassy of Italy, during their visit to the manufacturing facility of Bio-Labs in Islamabad.
They expressed their appreciation for the standards upheld by Bio-Labs in maintaining the quality of its products and commended the rapid growth in Bio-Labs’ exports. The meeting was filled with synergy and fruitful discussions. Our team’s professionalism and expertise were on full display, leaving a lasting impression on our esteemed guest.
The Trade Commissioner and First Secretary Counsel encouraged collaborative efforts for joint projects in pharmaceutical development and the production of food supplement products, emphasizing the potential for expansion in Italy.

 

 

Bio-Labs is thrilled to announce the launch of Omezka (Omeprazole B.P.) in our Pain and Gut Care Division. Omezka (Omeprazole B.P) is used to treat excess stomach acid in conditions such as non-cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome, and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from a group of medicines called Proton Pump Inhibitors.

At Bio-Labs, we are dedicated to advancing healthcare through innovation. Omezka stands as a testament to our commitment to well-being!

We at Bio-Labs are thrilled to unveil Lactenem (Meropenem USP) 500mg and 1gm IV Injection, a sterile and pyrogen-free synthetic carbapenem antibiotic designed for intravenous administration. Lactenem (Meropenem USP), offers a broad-spectrum solution for a range of infections in both adults and children. It is used to treat severe pneumonia, broncho-pulmonary infections in cystic fibrosis, complicated urinary tract infections, complicated intra-abdominal infections, intra and post-partum infections, and acute bacterial meningitis.

At Bio-Labs, we believe in the power of precise healthcare, and Lactenem (Meropenem USP) is proof of our dedication to advance and effective antibiotic therapy.

Bio-Labs is proud to announce the launch of Nextone (Ceftriaxone Sodium USP) I.V and I.M injection. Ceftriaxone is a third-generation cephalosporin antibiotic and has broad-spectrum activity. Nextone (Ceftriaxone Sodium USP) is used for the treatment of susceptible infections which include abdominal infections including Gastroenteritis (invasive salmonellosis; shigellosis), peritonitis, and biliary tract infections. Genital infections include gonorrhea, chancroid, Meningitis, septicemia, surgical infection (prophylaxis), Whipple’s disease, Lyme disease, Renal urinary, and respiratory tract infections.